| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Bolzon Bradley J Phd is a Director, 10% Owner at GLUE, with reported holdings spanning 3 companies. Recent filings cover 9 purchases and 194 sales. Those positions are worth an estimated $59.0M at current prices.
Our model assigns Bolzon Bradley J Phd a strong insider score of 75/100, based on 6 past trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +33.1%.
Bolzon Bradley J Phd's largest disclosed position is in GLUE as Director, 10% Owner, worth about $39.9M. Net of sales, the recent Form 4 record there shows accumulation of 157,895 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2020 | BDTX Black Diamond Therapeutics, Inc. | Director, 10% Owner | Sell | 17,240 | $33.30 | $574,015.38 | -0.3% | |
| Oct 12, 2020 | BDTX Black Diamond Therapeutics, Inc. | Director, 10% Owner | Sell | 22,625 | $33.50 | $757,923.76 | -0.4% | |
| Oct 7, 2020 | BDTX Black Diamond Therapeutics, Inc. | Director, 10% Owner | Sell | 45,926 | $33.44 | $1,535,732.23 | -0.8% | |
| Sep 18, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 3,035 | $86.87 | $263,635.88 | -0.6% | |
| Sep 16, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 8,965 | $86.98 | $779,777.49 | -1.7% | |
| Sep 14, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 1,155 | $84.89 | $98,045.29 | -0.2% | |
| Sep 10, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 22,845 | $85.36 | $1,949,996.35 | -4.1% | |
| Sep 1, 2020 | CRSP Crispr Therapeutics AG | Director | Sale+OE | 60,000 | $92.51 | $5,550,644.20 | - | |
| Aug 11, 2020 | BDTX Black Diamond Therapeutics, Inc. | Director, 10% Owner | Sell | 13,792 | $33.06 | $455,989.34 | -0.2% | |
| Jul 6, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 20,000 | $82.39 | $1,647,730.03 | -3.5% |